Search

Your search keyword '"Bilezikian J"' showing total 41 results

Search Constraints

Start Over You searched for: Author "Bilezikian J" Remove constraint Author: "Bilezikian J" Topic parathyroid hormone Remove constraint Topic: parathyroid hormone
41 results on '"Bilezikian J"'

Search Results

1. Use of parathyroid hormone in hypoparathyroidism.

2. Improved adherence with PTH(1-84) in an extension trial for 24 months results in enhanced BMD gains in the treatment of postmenopausal women with osteoporosis.

3. Catabolic and anabolic actions of parathyroid hormone on the skeleton.

4. Parathyroid hormone stimulates circulating osteogenic cells in hypoparathyroidism.

5. Therapy of hypoparathyroidism with intact parathyroid hormone.

6. Hetereogeneity in skeletal response to full-length parathyroid hormone in the treatment of osteoporosis.

7. Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis.

8. Parathyroid hormone as an anabolic therapy for women and men.

9. Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment.

10. The anabolic effects of parathyroid hormone.

11. Therapy of male osteoporosis with parathyroid hormone.

12. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study.

13. Signaling pathway and chronotropic action of parathyroid hormone in isolated perfused rat heart.

14. Fragment-specific actions of parathyroid hormone in isolated perfused rat hearts.

15. Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers.

16. Parathyroid hormone. Does it have a role in the pathogenesis of osteoporosis?

17. Primary hyperparathyroidism: pathophysiology and impact on bone.

18. Influence of antiresorptive agent OST-766 on signal transduction pathways involved in parathyroid hormone action.

19. Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism.

20. Positive chronotropic actions of parathyroid hormone and parathyroid hormone-related peptide are associated with increases in the current, I(f), and the slope of the pacemaker potential.

21. The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH-related protein.

22. Primary hyperparathyroidism and parathyroid hormone-related protein.

23. Effects of guanine nucleotides and parathyroid hormone on inositol 1,4,5-trisphosphate metabolism in canine renal cortical tubular cell membranes.

25. Suppression of parathyroid hormone secretion with oral calcium in normal subjects and patients with primary hyperparathyroidism.

26. Parathyroid hormone stimulates formation of inositol phosphates in a membrane preparation of canine renal cortical tubular cells.

27. The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects.

28. Abnormalities in parathyroid hormone secretion and 1,25-dihydroxyvitamin D3 formation in women with osteoporosis.

30. Stimulation of inositol phosphate formation in ROS 17/2.8 cell membranes by guanine nucleotide, calcium, and parathyroid hormone.

31. The preoperative localization of hyperfunctioning parathyroid tissue utilizing parathyroid hormone radioimmunoassay of plasma from selectively catheterized thyroid veins.

32. Enhancement of parathyroid hormone-responsive renal cortical adenylate cyclase activity by a cytosol protein activator from rat reticulocytes.

33. Preoperative localization of hyperfunctioning parathyroid tissue: radioimmunoassay of parathyroid hormone in plasma from selectively catheterized thyroid veins.

34. Preoperative localization of abnormal parathyroid tissue. Cumulative experience with venous sampling and arteriography.

35. Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trial.

36. Glucocorticoid-induced osteoporosis and parathyroid hormone

37. Bone imaging in hypoparathyroidism.

38. The role of calcimimetics in the treatment of hyperparathyroidism.

39. Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features.

40. Primary hyperparathyroidism: pathophysiology and impact on bone.

41. Surgery or no surgery for primary hyperparathyroidism.

Catalog

Books, media, physical & digital resources